LONDON – Studies have shown that marijuana not only helps fight the symptoms of treating cancer but also the disease itself. THC, or tetrahydrocannabinol, often gets the credit for battling cancer cells, but a new study shows that THC isn’t working alone. The study conducted at St. George’s University of London, led by Dr. Wai Liu, examined six […]
Read More Anti-Cancer Properties of Medical Marijuana Revealed in its entirety on The Daily Chronic.
Want to stay up to date on marijuana reform & cannabis news worldwide? Visit The Daily Chronic - The Voice of the Reform Generation, the most comprehensive coverage of the cannabis community!READ MORE
Pulmonary complications associated with the regular smoking of cannabis are “relatively small” and far lower than those associated with tobacco smoking, according to a recent review published in the June edition of the scientific journal Annals of the American Thoracic Society.
The paper – authored by Donald P. Tashkin, MD, emeritus professor of medicine and medical director of the Pulmonary Function Laboratory at the David Geffen School of Medicine at University of California, Los Angeles – is “the most comprehensive and authoritative review of the subject ever published,” according to an accompanying commentary. Donald Tashkin conducted US-government sponsored studies of marijuana and lung function for over 30 years.
His review finds that although smoking cannabis may be associated with symptoms of chronic bronchitis, studies do not substantiate claims that it is positively associated with the development of lung cancer, chronic obstructive pulmonary disease (COPD), emphysema, or bullous lung disease.
“[H]abitual use of marijuana alone does not appear to lead to significant abnormalities in lung function,” Tashkin writes. “[F]indings from a limited number of well-designed epidemiological studies do not suggest an increased risk of either lung or upper airway cancer from light or moderate use. … Overall. . . . . READ MORE
GAINESVILLE, FL — The legalization of marijuana for medical purposes does not lead to an increase in teen marijuana use, according to a new study by researchers at the University of Florida College of Medicine in Gainseville.
The study, published in the American Journal of Public Health, used data collected from the Youth Risk Behavior Survey for the states of Montana, Rhode Island, Michigan, and Delaware compiled over an eight year period.
“Our results suggest that, in the states assessed here, MMLs [medical marijuana laws] have not measurably affected adolescent marijuana use in the first few years after their enactment,” researchers wrote in their conclusion. ”Longer-term results, after MMLs are more fully implemented, might be different.”
The study confirms the results of a similar studies conducted in years past, while contradicting public statements made by Drug Czar Gil Kerlikowske and other medical marijuana opponents, who repeatedly allege that the passage of medical marijuana laws is directly responsible for higher levels of self-reported marijuana consumption among U.S. teenagers.
A study conducted last year by researchers from Montana State University, the University of Oregon, and the University of Colorado, Denver examined the relationship between st. . . . . READ MORE